Brief: Fujirebio Says Entered Into Agreement With Janssen Pharmaceuticals

H.U. group

26/04/2018 12:51

April 26 (Reuters) - Miraca Holdings Inc  4544.T :
    * FUJIREBIO SAYS ENTERED INTO AGREEMENT WITH JANSSEN
PHARMACEUTICALS TO DEVELOP & COMMERCIALIZE AMYLOID Β 42/40 RATIO
ASSAY
    * FUJIREBIO - ASSAY INTENDED TO IDENTIFY PATIENTS WHO MAY
BENEFIT
FROM TREATMENT WITH JANSSEN'S NEW INVESTIGATIONAL ORAL BACE
INHIBITOR, ATABECESTAT

Source text for Eikon:  ID:nBw8Wx34la 
Further company coverage:  4544.T 

 ((Reuters.Briefs@thomsonreuters.com;))